KYMR – Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.KYMR
$64.10Name : Kymera Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,611,932,160.00
EPSttm : -3.6
Kymera Therapeutics, Inc.
$64.10
1.29%$0.84Float Short %
13.52
Margin Of Safety %
Put/Call OI Ratio
0.99
EPS Next Q Diff
-0.06
EPS Last/This Y
-0.5
EPS This/Next Y
-0.39
Price
64.05
Target Price
76.14
Analyst Recom
1.04
Performance Q
50.58
Relative Volume
0.55
Beta
2.28
Ticker: KYMR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | KYMR | 60.5 | 0.48 | 0.02 | 2630 |
| 2025-10-21 | KYMR | 58.35 | 0.47 | 7.75 | 2676 |
| 2025-10-22 | KYMR | 55.77 | 0.48 | 0.04 | 2708 |
| 2025-10-23 | KYMR | 57.75 | 0.49 | 0.03 | 2705 |
| 2025-10-24 | KYMR | 58.53 | 0.48 | 0.20 | 2741 |
| 2025-10-27 | KYMR | 60.88 | 0.48 | 0.03 | 2745 |
| 2025-10-28 | KYMR | 61.99 | 0.47 | 999.99 | 2777 |
| 2025-10-29 | KYMR | 60.12 | 0.47 | 999.99 | 2777 |
| 2025-10-30 | KYMR | 61.46 | 0.47 | 999.99 | 2778 |
| 2025-10-31 | KYMR | 61.87 | 0.47 | 0.04 | 2777 |
| 2025-11-03 | KYMR | 59.69 | 0.46 | 0.10 | 2816 |
| 2025-11-04 | KYMR | 59.99 | 0.46 | 999.99 | 2810 |
| 2025-11-05 | KYMR | 59.91 | 0.46 | 0.01 | 2812 |
| 2025-11-06 | KYMR | 61 | 0.44 | 4.75 | 2904 |
| 2025-11-07 | KYMR | 58.79 | 0.44 | 0.00 | 2905 |
| 2025-11-10 | KYMR | 61.27 | 0.44 | 0.00 | 2913 |
| 2025-11-11 | KYMR | 63.42 | 0.48 | 0.00 | 2759 |
| 2025-11-12 | KYMR | 63.58 | 0.47 | 0.05 | 2792 |
| 2025-11-13 | KYMR | 63.57 | 0.47 | 53.64 | 2810 |
| 2025-11-14 | KYMR | 64.95 | 0.86 | 1.75 | 3562 |
| 2025-11-17 | KYMR | 64.09 | 0.99 | 2.00 | 4461 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | KYMR | 60.50 | 5.0 | -45.4 | -3.41 |
| 2025-10-21 | KYMR | 58.31 | 4.8 | -28.1 | -3.41 |
| 2025-10-22 | KYMR | 55.80 | 4.0 | -25.4 | -3.42 |
| 2025-10-23 | KYMR | 57.78 | 4.0 | -54.5 | -3.42 |
| 2025-10-24 | KYMR | 58.56 | 4.0 | -46.4 | -3.42 |
| 2025-10-27 | KYMR | 60.88 | 4.0 | -55.8 | -3.42 |
| 2025-10-28 | KYMR | 61.95 | 4.0 | -47.9 | -3.42 |
| 2025-10-29 | KYMR | 60.08 | 4.0 | -30.3 | -3.42 |
| 2025-10-30 | KYMR | 61.44 | 4.0 | -49.4 | -3.42 |
| 2025-10-31 | KYMR | 61.84 | 4.0 | -43.7 | -3.42 |
| 2025-11-03 | KYMR | 59.66 | 4.1 | -28.5 | -3.42 |
| 2025-11-04 | KYMR | 60.03 | 4.1 | -43.2 | -3.42 |
| 2025-11-05 | KYMR | 59.81 | 4.1 | -40.7 | -3.42 |
| 2025-11-06 | KYMR | 60.99 | 4.1 | -28.2 | -3.42 |
| 2025-11-07 | KYMR | 58.66 | 3.5 | -8.2 | -3.52 |
| 2025-11-10 | KYMR | 61.26 | 3.5 | -36.2 | -3.52 |
| 2025-11-11 | KYMR | 63.37 | 5.0 | -33.7 | -3.49 |
| 2025-11-12 | KYMR | 63.55 | 5.0 | -22.4 | -3.49 |
| 2025-11-13 | KYMR | 63.62 | 6.0 | -22.1 | -3.48 |
| 2025-11-14 | KYMR | 64.86 | 6.0 | -28.4 | -3.48 |
| 2025-11-17 | KYMR | 64.05 | 6.0 | -16.8 | -3.48 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | KYMR | 6.29 | 7.52 | 13.69 |
| 2025-10-21 | KYMR | 6.29 | 7.52 | 13.69 |
| 2025-10-22 | KYMR | 6.29 | 7.52 | 13.69 |
| 2025-10-23 | KYMR | 6.29 | 7.52 | 13.69 |
| 2025-10-24 | KYMR | 6.29 | 7.52 | 13.69 |
| 2025-10-27 | KYMR | 6.29 | 7.98 | 13.74 |
| 2025-10-28 | KYMR | 6.29 | 7.98 | 13.74 |
| 2025-10-29 | KYMR | 6.29 | 7.98 | 13.74 |
| 2025-10-30 | KYMR | 6.02 | 7.98 | 13.74 |
| 2025-10-31 | KYMR | 6.02 | 7.98 | 13.74 |
| 2025-11-03 | KYMR | 6.02 | 7.30 | 13.74 |
| 2025-11-04 | KYMR | 6.02 | 7.30 | 13.74 |
| 2025-11-05 | KYMR | 6.04 | 7.30 | 13.74 |
| 2025-11-06 | KYMR | 6.02 | 7.30 | 13.74 |
| 2025-11-07 | KYMR | 5.98 | 7.30 | 13.66 |
| 2025-11-10 | KYMR | 5.98 | 7.17 | 13.66 |
| 2025-11-11 | KYMR | 5.98 | 7.17 | 13.66 |
| 2025-11-12 | KYMR | 5.98 | 7.17 | 13.54 |
| 2025-11-13 | KYMR | 5.98 | 7.17 | 13.54 |
| 2025-11-14 | KYMR | 5.98 | 7.17 | 13.52 |
| 2025-11-17 | KYMR | 6.00 | 6.28 | 13.52 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.94
Avg. EPS Est. Current Quarter
-0.84
Avg. EPS Est. Next Quarter
-1
Insider Transactions
6
Institutional Transactions
6.28
Beta
2.28
Average Sales Estimate Current Quarter
15
Average Sales Estimate Next Quarter
11
Fair Value
Quality Score
25
Growth Score
26
Sentiment Score
98
Actual DrawDown %
30.3
Max Drawdown 5-Year %
-87.5
Target Price
76.14
P/E
Forward P/E
PEG
P/S
105.46
P/B
4.86
P/Free Cash Flow
EPS
-3.6
Average EPS Est. Cur. Y
-3.48
EPS Next Y. (Est.)
-3.87
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-674.81
Relative Volume
0.55
Return on Equity vs Sector %
-58.1
Return on Equity vs Industry %
-43.2
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.06
EBIT Estimation
-16.8
Kymera Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 225
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
stock quote shares KYMR – Kymera Therapeutics, Inc. Stock Price stock today
news today KYMR – Kymera Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KYMR – Kymera Therapeutics, Inc. yahoo finance google finance
stock history KYMR – Kymera Therapeutics, Inc. invest stock market
stock prices KYMR premarket after hours
ticker KYMR fair value insiders trading